# clm_3E5F56BC8504

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 439,664,000 United States dollar  
valid_from: 2013-03-31  
valid_to: 2013-06-30  
published: 2013-05-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_176F45465AD1  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 439,664,000 United States dollar", as of 2013-03-31 (until 2013-06-30). Claim clm_3E5F56BC8504, https://asof.is/claim/clm_3E5F56BC8504, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q1 FY2013, filed 2013-05-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217613000008/0001532176-13-000008-index.htm (primary, SEC EDGAR 10-Q Q1 FY2013, published 2013-05-03)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 427,687,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_3E5F56BC8504](/claim/clm_3E5F56BC8504.md) | [clm_82AF3B3F2E9E](/claim/clm_82AF3B3F2E9E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.